Dave St Jean Email & Phone Number | I am a Sr Vice President of Chemistry - Head of Late Discovery at Odyssey Therapeutics. I have over 20 years of industrial experience in medicinal chemistry, drug design, and drug discovery across multiple therapeutic areas, including neuroscience, pain, diabetes, and oncology. As a leader of a large and multidisciplinary team of chemists, biologists, pharmacologists, and DMPK experts, I oversee the strategy, execution, and delivery of high-quality small molecule drug candidates from hit identification to clinical development. I have contributed to the discovery of several clinical candidates, some of which are currently in phase I/II trials. I am also a prolific author and inventor, with 40 publications in high-impact journals and 30 published patent applications.

Dave St Jean

I am a Sr Vice President of Chemistry - Head of Late Discovery at Odyssey Therapeutics. I have over...
2 Leon Road, Holbrook, United States

*50 free lookup(s) per month.

Dave St Jean’s Phone Numbers

Get DAVE’s Phone Number (For Free)

Social Media

Dave St Jean’s Location 2 Leon Road, Holbrook, United States

Dave St Jean’s Current Industry Odyssey Therapeutics

Dave St Jean’s Prior Industry Scorpion Therapeutics | Grunenthal | Amgen

Find accurate emails & phone numbers for over 700M professionals.

Senior Vice President Chemistry, Head of Late Discovery

2024-08-01 00:00:00 - Present

Vice President of Chemistry

2020-07-01 00:00:00 - 2024-08-01 00:00:00

Sr. Director Neuroscience/Pain - Chemistry

2019-10-01 00:00:00 - 2020-07-01 00:00:00

Director - Medicinal Chemistry

2018-08-01 00:00:00 - 2019-10-01 00:00:00

No Skills Available

No Languages Available

Dave St Jean is a I am a Sr Vice President of Chemistry - Head of Late Discovery at Odyssey Therapeutics. I have over 20 years of industrial experience in medicinal chemistry, drug design, and drug discovery across multiple therapeutic areas, including neuroscience, pain, diabetes, and oncology. As a leader of a large and multidisciplinary team of chemists, biologists, pharmacologists, and DMPK experts, I oversee the strategy, execution, and delivery of high-quality small molecule drug candidates from hit identification to clinical development. I have contributed to the discovery of several clinical candidates, some of which are currently in phase I/II trials. I am also a prolific author and inventor, with 40 publications in high-impact journals and 30 published patent applications.